IMM 23.0% 33.5¢ immutep limited

expecting income.

  1. 106 Posts.
    Are we expecting income?

    It was announced prior to cap raising cvac has been granted approval for commercialization in the middle east.


    "Significant opportunity for Prima to tap into US$517 million Middle East cancer therapy market."

    "First commercial sales of CVac anticipated in 2011."

    The first is a very open statement, how much of this market estimation is related to ovarian cancer therapy?
    1mil, 5mi, 15mil, 50mil?


    The later, anticipates sales during 2011. Assuming PRR brings in revenue. Will these figures appear in the next round of financial reportings?

    It would be great to see some revenue so early from the main drug, even if it was only a few million.

 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
33.5¢
Change
-0.100(23.0%)
Mkt cap ! $486.6M
Open High Low Value Volume
39.0¢ 40.0¢ 23.0¢ $16.23M 50.19M

Buyers (Bids)

No. Vol. Price($)
4 704297 33.0¢
 

Sellers (Offers)

Price($) Vol. No.
33.5¢ 102135 2
View Market Depth
Last trade - 16.10pm 27/06/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.